| Financial Year |
March 31 2023 |
| Monetary Funds |
407,931,479.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
129,371,451.48 |
| Advances to Suppliers |
13,312,021.17 |
| Other Receivables |
16,244,764.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
197,473,288.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,942,564.54 |
| Total Current Assets |
766,275,570.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
801,155.73 |
| Investment Properties |
-- |
| Fixed Assetes |
629,142,125.19 |
| Under-construction Projects |
37,284,318.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,314,016.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,947,398.38 |
| Deferred Income Tax Assets |
46,572,773.72 |
| Other Non-Current Assets |
20,748,111.34 |
| Sub-Total of Non-Current Assets |
855,556,999.74 |
| Total Assets |
1,621,832,569.79 |
| Short-Term Loans |
686,360,215.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
258,239,300.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,067,615.60 |
| Taxes Payable |
9,326,023.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,993,107.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,058,839.75 |
| Other Current Liabilities |
5,559,495.78 |
| Sub-Total of Current Liabilities |
1,071,369,949.97 |
| Long-term Loans |
29,537,858.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
59,761,481.41 |
| Total Liabilities |
1,131,131,431.38 |
| Paid-In Capital(Or Share Stock) |
244,642,300.00 |
| Capital Surplus |
205,239,617.73 |
| Surplus Reserve |
27,047,256.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,012,412.51 |
| Minority Stockholder's Interest |
11,759,551.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
478,941,586.51 |
| Owner's Equity（Stockholder's Equity） |
490,701,138.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,621,832,569.79 |
